CD8A and neoplasm: We determined CD122 expression and proliferation of tumor-specific CD8+ T cells using the M8 and the AH1 MHC-I tetramer for the B16-CD133 and the C51 model, respectively (Fig. 1f–j, and Supplementary Fig. 3a, b).